In weighing legislation to establish President Biden’s proposed Advanced Research Projects Agency for Health to speed development of breakthrough treatments, Congress should consider the possible impact of crowding out private sector investment in research and whether alternative approaches may make sense, according to a report released by the Congressional Research Service on 18 May.
The CRS report reviews the proposal in the Administration’s recently released “skinny” federal budget for 2022 to dedicate $6.5bn...






